MGC Pharmaceuticals’ “numbers were very good” in Q4 2022

–News Direct–

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner about how the business performed during the fourth quarter of 2022. Clements says that the “numbers were very good” and reveals more details about how the business is changing as it heads into a new calendar year.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/mgc-pharmaceuticals-numbers-were-very-good-in-q4-2022-130248078